These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11449124)

  • 1. [Lymphoproliferative disorders after liver transplantation].
    Pageaux GP
    Gastroenterol Clin Biol; 2001 Apr; 25(4):357-66. PubMed ID: 11449124
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphoproliferative disorders after liver transplantation.
    Leblond V; Choquet S
    J Hepatol; 2004 May; 40(5):728-35. PubMed ID: 15094218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis and treatment of de novo malignancy after liver transplantation].
    Zhu ZJ; Li L; Zhang YM
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):237-8. PubMed ID: 17649647
    [No Abstract]   [Full Text] [Related]  

  • 4. Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?
    Aucejo F; Rofaiel G; Miller C
    J Hepatol; 2006 Jan; 44(1):19-23. PubMed ID: 16298453
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancies after liver transplantation: a comparative review.
    Tan-Shalaby J; Tempero M
    Semin Liver Dis; 1995 May; 15(2):156-64. PubMed ID: 7660168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
    Bar-Natan M; Nagler A
    Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060
    [No Abstract]   [Full Text] [Related]  

  • 8. Withdrawal of immunosuppression in liver transplantation: lessons learned from PTLD.
    Mazariegos GV
    Pediatr Transplant; 2004 Jun; 8(3):210-3. PubMed ID: 15176955
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-Transplantation Lymphoproliferative Disorders in Adults.
    Dierickx D; Habermann TM
    N Engl J Med; 2018 Feb; 378(6):549-562. PubMed ID: 29414277
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors and pathogenesis of posttransplant lymphoproliferative disorders.
    Ho M
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):38-40. PubMed ID: 7482816
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome.
    Fernández MC; Bes D; De Dávila M; López S; Cambaceres C; Dip M; Imventarza O
    Pediatr Transplant; 2009 May; 13(3):307-10. PubMed ID: 18346039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is hepatitis B virus reactivation a risk factor in the development of posttransplant lymphoproliferative disorder following liver transplantation?
    Luo Y; Zhang AB; Huang H; Zheng SS
    Chin Med J (Engl); 2008 Jul; 121(13):1237-40. PubMed ID: 18710646
    [No Abstract]   [Full Text] [Related]  

  • 13. What is the current treatment of PTLD after liver transplantation?
    Dufour JF; Fey MF
    J Hepatol; 2006 Jan; 44(1):23-6. PubMed ID: 16290906
    [No Abstract]   [Full Text] [Related]  

  • 14. Posttransplantation lymphoproliferative disorders.
    Andreone P; Gramenzi A; Lorenzini S; Biselli M; Cursaro C; Pileri S; Bernardi M
    Arch Intern Med; 2003 Sep; 163(17):1997-2004. PubMed ID: 14504111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous involvement of polymorphic post-transplant lymphoproliferative disorder in a child after liver transplantation.
    Chen KY; Lin CY; Kuo TT; Shih LY; Chang CH; Chen WT; Yang CY
    Pediatr Dermatol; 2019 Sep; 36(5):681-685. PubMed ID: 31215060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation.
    Zein NN; Perez RG; Wiesner RH
    Hepatology; 2000 Mar; 31(3):808-9. PubMed ID: 10722316
    [No Abstract]   [Full Text] [Related]  

  • 17. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
    Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of transplant-related lymphoproliferative diseases.
    Benkerrou M; Durandy A; Brousse N; Fischer A
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):55-9. PubMed ID: 8390048
    [No Abstract]   [Full Text] [Related]  

  • 19. Otolaryngologic management of posttransplant lymphoproliferative disease in children.
    Sculerati N; Arriaga M
    Ann Otol Rhinol Laryngol; 1990 Jun; 99(6 Pt 1):445-50. PubMed ID: 2350129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent increased Epstein-Barr virus loads after solid organ transplantation: truth and consequences?
    Green M; Webber SA
    Liver Transpl; 2007 Mar; 13(3):321-2. PubMed ID: 17318870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.